Humans have a complicated symbiotic relationship with their gut microbiome, which is
postulated to impact host health and disease broadly. Epigenetic alterations allow host cells …

Non-alcoholic fatty liver disease (NAFLD) is considered to be a significant health threat
globally, and has attracted growing concern in the research field of liver diseases. NAFLD …

Background: Non-alcoholic fatty liver disease (NAFLD) represents the most common form of
chronic liver disease that urgently needs effective therapy. Rosavin, a major constituent of …

The gut microbiota features an abundance of diverse microorganisms and represents an
important component of human physiology and metabolic homeostasis, indicating their roles …

Radiation-induced pulmonary fibrosis (RIPF) is a major side effect experienced for patients
with thoracic cancers after radiotherapy. RIPF is poor prognosis and limited therapeutic …

Short-chain fatty acids (SCFAs) are crucial gut microbial metabolites that play a major role in
the occurrence and development of hepatic fibrosis (HF). However, the effect of SCFAs on …

Given the increasing worldwide prevalence of non-alcoholic fatty liver disease (NAFLD) and
a lack of approved medication, the development of effective nutritional supplements for …

Non-alcoholic steatohepatitis (NASH) is the clinically aggressive variant of non-alcoholic
fatty liver disease. Hippo pathway dysregulation can contribute to NASH development and …

Abstract Background Nonalcoholic Steatohepatitis (NASH) results from complex liver
conditions involving metabolic, inflammatory, and fibrogenic processes. Despite its burden …

Hepatobiliary diseases have a high prevalence worldwide, with a wide range of diseases
involved in the liver and biliary system. Modifications in gut microbiota have been proven to …